Hyperthyroidism / Thyroid Storm: Management Decision Model

---

Clinical Templates

Hyperthyroidism — Asymptomatic or Mild

The patient is tachycardic but hemodynamically stable with no end-organ dysfunction or AMS. Burch-Wartofsky score is low (less than 25), indicating thyroid storm is unlikely. The hyperthyroidism is compensated, and emergency treatment beyond symptom control is not required.

Plan: Beta-blocker therapy (propranolol 60-80 mg PO every 4-6 hours or atenolol 50-100 mg PO daily) is initiated for rate control and symptom relief. Antiemetics or acetaminophen may be given for comfort. Do not start thionamide therapy in the ED—this is an outpatient endocrinology initiation. Arrange urgent follow-up with primary care or endocrinology (within 3-7 days) to initiate definitive thyroid suppression (PTU or methimazole) and evaluate for the underlying cause (Graves disease, nodular disease, thyroiditis). Patient is discharged home with clear instructions to return if fever, chest pain, severe palpitations, or altered mental status develops.

---

Thyrotoxicosis — Symptomatic / Impending Storm

The patient has clinical features of thyrotoxicosis (palpitations, tremor, diaphoresis, possibly low-grade fever or GI symptoms) and the Burch-Wartofsky score suggests impending thyroid storm (score 25-44), indicating significant risk of progression. End-organ effects are present but the patient remains hemodynamically compensated and alert.

Plan: IV access is obtained immediately. Beta-blockade is achieved with propranolol IV (1-2 mg IV over 10 minutes, repeated boluses every 15 minutes until heart rate is less than 100 bpm, then transition to drip 3-5 mg/hour and PO dosing once stable). Thionamide is loaded: PTU 500-1000 mg PO or PR, then 250 mg every 4 hours. One hour after thionamide initiation, iodine is given as SSKI or Lugol’s solution (5 drops every 6 hours) to block thyroid hormone release. Hydrocortisone 100 mg IV every 8 hours is given to block T4-to-T3 conversion and manage possible adrenal insufficiency. Acetaminophen is used for fever; aggressive cooling is initiated if hyperthermic. Agitation is managed with benzodiazepines. A careful search for precipitating factors (infection, medications, recent iodine contrast, surgery, or medication non-compliance) is performed and addressed. The patient is admitted to an inpatient medicine service for continued monitoring and definitive care. Thyroid function tests (TSH, free T4), complete metabolic panel, liver function tests, CBC, and ECG are obtained. The endocrinology service is notified and consulted as appropriate.

---

Thyroid Storm

The patient presents with multi-organ dysfunction: marked fever, AMS or psychosis, tachycardia often exceeding 140 bpm with hemodynamic instability, atrial fibrillation with rapid ventricular response, acute heart failure, and possible GI manifestations (vomiting, diarrhea, hepatomegaly) or hepatic dysfunction. Burch-Wartofsky score is high (≥45), and this is a true endocrine emergency with mortality exceeding 10% even with treatment. This is a medical crisis requiring ICU-level care.

Plan: Immediate ICU consultation and admission. Central line placement is considered for hemodynamic monitoring and medication administration. Aggressive IV beta-blockade is initiated: propranolol 1-2 mg IV over 10 minutes, repeat boluses every 15 minutes until heart rate is less than 100 bpm, then continuous drip at 3-5 mg/hour. If contraindicated by asthma or heart failure, esmolol is used (loading dose 250-500 mcg/kg IV, infusion 50-100 mcg/kg/min titrated to effect). Simultaneously, PTU is loaded at 500-1000 mg PO, PR, or NG (if available; IV is not standard), then 250 mg every 4 hours to block thyroid hormone synthesis and T4-to-T3 conversion. One hour after PTU initiation, iodine is administered: SSKI 5 drops every 6 hours or Lugol’s solution 5 drops every 6 hours (critical that PTU precedes iodine to prevent worsening thyroid hormone release). Hydrocortisone 100 mg IV every 8 hours is given to block peripheral T4-to-T3 conversion and to manage adrenal insufficiency. Aggressive fever management is undertaken: acetaminophen (not aspirin, which displaces T4 from binding proteins and worsens thyrotoxicosis), aggressive external cooling (ice packs, cooling blankets, cold IV fluids), and if necessary, cooling catheters. Benzodiazepines are used liberally for agitation and anxiety (lorazepam 2-4 mg IV every 2-4 hours). Fluid resuscitation with IV crystalloid is given for volume depletion from fever and diaphoresis. Atrial fibrillation is rate-controlled with beta-blockade; consider digoxin if inotropic support is needed (beta-blockers may be insufficient in decompensated heart failure). Hypothermia or bradycardia from over-treatment is monitored closely. Aggressive search for precipitating factors is performed: CXR for infection, blood cultures if febrile, ECG for ischemia or arrhythmia, abdominal exam for acute abdomen. Recent medication review is critical, especially iodine-containing contrast or amiodarone. Thyroid function tests, comprehensive metabolic panel, liver and renal function, CBC, coagulation studies, troponin, and lactate are drawn urgently. If the etiology is amiodarone-induced thyrotoxicosis (Type 2 destructive thyroiditis), iodine is contraindicated and steroids become the mainstay of therapy. Close coordination with ICU, endocrinology, and internal medicine is essential. Mechanical ventilation may become necessary if respiratory distress develops from heart failure or altered consciousness.

---

Burch-Wartofsky Point Scale

The Burch-Wartofsky Point Scale (BWPS) is a validated scoring tool that stratifies the risk of thyroid storm in patients with thyrotoxicosis. ^[1] It assigns points across five clinical domains: thermoregulatory dysfunction, CNS manifestations, GI-hepatic dysfunction, cardiovascular dysfunction, and presence of a precipitating event. The scale is used at the bedside to risk-stratify and guide decision-making.

Clinical Parameter	Findings	Points
Thermoregulatory Dysfunction
Temperature (°F)	99–99.9 / 100–100.9 / 101–101.9 / ≥102	5 / 10 / 15 / 20
CNS Effects
Mild (agitation, anxiety)	Present	10
Moderate (delirium, psychosis, lethargy)	Present	20
Severe (seizures, coma)	Present	30
GI-Hepatic Dysfunction
Nausea/vomiting	Present	10
Abdominal pain, diarrhea	Present	10
Jaundice, hepatomegaly, elevated transaminases	Present	10
Cardiovascular Dysfunction
Tachycardia (HR bpm)	90–109 / 110–119 / 120–129 / ≥130	5 / 10 / 15 / 20
Atrial fibrillation	Present	10
Congestive heart failure	Present	10
Precipitating Factors
Infection, surgery, trauma, emotional stress, etc.	Present	10

Risk Stratification:

• Score <25: Thyroid storm is unlikely. Supportive care and outpatient follow-up.
• Score 25–44: Impending thyroid storm. Aggressive treatment (thionamide, iodine, beta-blockade, steroids) and hospital admission are indicated.
• Score ≥45: Thyroid storm is highly suggestive. Full treatment cascade, ICU admission, and immediate intervention are mandatory.

MDCalc: Burch-Wartofsky Point Scale Calculator

---

Treatment Cascade: The Critical Order

The sequence of thyroid storm treatment is non-negotiable. ^{[1] [3]} Each step builds on the previous one, and deviating from this order can worsen outcomes. The mnemonic BETA-IS may help: Beta-blocker, Endocrine (thionamide), Then Antithyroid (iodine), Iodine (only after 1 hour), Steroids.

Step	Agent	Dosing	Rationale
1. Beta-blockade	Propranolol (preferred) or esmolol	IV: 1–2 mg over 10 min, repeat q15min until HR <100, then 3–5 mg/hr drip. PO: 60–80 mg q4–6h. Esmolol: 250–500 mcg/kg load, 50–100 mcg/kg/min infusion.	Immediate symptom control (palpitations, tremor). [5] [10] Propranolol also blocks T4→T3 conversion (unique advantage). Esmolol for asthma or heart failure.
2. Thionamide	PTU (preferred in storm) or methimazole	PTU: 500–1000 mg load (PO/PR/NG), then 250 mg q4h. Methimazole: 20–25 mg q4h PO.	Blocks thyroid hormone synthesis. [9] PTU preferred because it also blocks T4→T3 conversion. Check LFTs before PTU (risk of hepatotoxicity). Onset ~30–60 min.
3. Iodine (MUST wait 1 hour)	SSKI or Lugol’s solution	5 drops q6h (SSKI ≈ 50 mg I per drop; Lugol’s ≈ 15 mg I per drop)	Blocks thyroid hormone release (Wolff-Chaikoff effect). [2] CRITICAL: Must follow thionamide by ≥1 hour, else iodine will worsen synthesis. Contraindicated in amiodarone-induced Type 2 thyroiditis.
4. Steroids	Hydrocortisone or dexamethasone	Hydrocortisone: 100 mg IV q8h. Dexamethasone: 4 mg IV q6h.	Blocks T4→T3 conversion. [5] [10] Manages underlying adrenal insufficiency (common in thyroid storm). Both agents have similar efficacy; choice depends on availability.
5. Supportive	Acetaminophen, cooling, fluids, benzodiazepines	Fever: Acetaminophen (NOT aspirin) + external cooling + ice packs. Agitation: Lorazepam 2–4 mg IV q2–4h. Volume: IV crystalloid.	Symptomatic relief and organ protection. Aspirin displaces T4 from proteins and worsens thyrotoxicosis—avoid. Ensure adequate hydration for fever losses and reduced peripheral resistance.

Why Order Matters: If iodine is given before thionamide, the newly synthesized thyroid hormone will be rapidly released into circulation, precipitating or worsening thyroid storm. Beta-blockade must precede aggressive treatment to prevent iatrogenic cardiac complications. Steroids provide both symptom relief (T4→T3 conversion block) and treatment of presumed adrenal insufficiency.

---

Precipitant Search

Thyroid storm rarely occurs de novo in a patient with underlying thyrotoxicosis. ^{[1] [3]} An identifiable precipitating event is present in the vast majority of cases and must be aggressively sought and treated. Common precipitants include:

• Infection: UTI, pneumonia, appendicitis, or other bacterial or viral infection. Fever and elevated acute phase reactants are present. Obtain CXR, urinalysis, blood cultures, and abdominal imaging as clinically indicated.
• Surgery or trauma: Recent operation, injury, or stress can unmask or trigger thyroid storm hours to days afterward.
• Medication non-compliance: Abrupt discontinuation of PTU, methimazole, or beta-blockers is a common precipitant. Always ask specifically about recent changes in medications.
• Iodine exposure: Recent exposure to iodine-containing contrast (cardiac catheterization, CT angiography, angiography), amiodarone initiation, or iodinated antiseptics can precipitate thyroid storm in susceptible patients.
• Pregnancy or postpartum state: Gestational transient thyroiditis or postpartum thyroiditis can precipitate thyroid storm. Always ask about recent delivery or miscarriage.
• Emotional stress: Severe psychological stressor, grief, or acute life event.

The precipitant must be identified and managed concurrently with thyroid-specific treatment. Treatment of the underlying infection, reinstatement of antithyroid medications, or removal of the iodine source is essential for resolution of thyroid storm.

---

Amiodarone-Induced Thyrotoxicosis

Amiodarone, a potent antiarrhythmic drug rich in iodine content, can paradoxically cause thyrotoxicosis in 1–23% of treated patients, depending on baseline iodine intake and thyroid status. ^[4] Amiodarone-induced thyrotoxicosis (AIT) is classified into two types based on mechanism, and distinguishing between them is crucial because treatment differs fundamentally.

Type 1 AIT (Iodine-Induced): Occurs in patients with underlying thyroid disease (Graves disease, multinodular goiter, or latent hyperthyroidism) where the excess iodine substrate from amiodarone increases thyroid hormone synthesis. Treatment is thionamide-based: PTU or methimazole blocks new hormone synthesis. Beta-blockers and steroids provide symptom relief. These patients often improve over weeks to months as thyroid hormone stores deplete.

Type 2 AIT (Destructive Thyroiditis): Represents a direct toxic or inflammatory effect of amiodarone on the thyroid, causing release of preformed thyroid hormones without increased synthesis. ^[4] Thionamides are ineffective because the problem is not hormone synthesis but release. Treatment is steroid-based: Hydrocortisone 100 mg IV q8h or high-dose oral prednisone (60–80 mg daily) suppresses the inflammatory response. Beta-blockers provide rate control. These patients typically improve over days to weeks with steroid therapy.

Type 3 AIT (Iodine-Induced in Underlying Hypothyroidism): Rare; amiodarone causes thyrotoxicosis in a patient with pre-existing autoimmune hypothyroidism. Treated as Type 2 with steroids.

Clinical Pearl: Type 1 and Type 2 often coexist, making the distinction difficult. ^[4] When amiodarone-induced thyrotoxicosis is suspected, do NOT give iodine (SSKI, Lugol’s, or other iodine-containing solutions). Iodine will worsen Type 1 disease and is unnecessary in Type 2. Instead, initiate both PTU (for any component of synthesis) and high-dose steroids (for any component of thyroiditis). As amiodarone is highly lipophilic and long-acting, the drug is typically not discontinued immediately unless life-threatening arrhythmia develops, but β-blockade and steroid therapy are the mainstays. Discontinuation of amiodarone must be weighed against the risk of recurrent arrhythmia and discussed with cardiology.

---

Myxedema Coma: The Opposite Emergency

While thyroid storm represents the extreme of thyroid hormone excess, myxedema coma is the corresponding life-threatening emergency of thyroid hormone deficiency. ^[6] This occurs in severely hypothyroid patients (usually chronic severe hypothyroidism from Hashimoto’s disease) who decompensate with altered mental status, hypothermia, bradycardia, hypotension, and hypoventilation. Myxedema coma carries a mortality rate of 20–50% even with treatment and requires ICU admission.

Clinical Presentation: Severe hypothermia (core temperature often 32–35°C), profound bradycardia, hypotension, altered mental status or coma, hypoventilation or respiratory depression, and often a precipitating factor such as infection, sedative use, or abrupt levothyroxine discontinuation.

Treatment: IV levothyroxine is the cornerstone: loading dose 200–400 mcg IV once, then 50–100 mcg IV daily until the patient can tolerate PO therapy. ^[6] Concurrent IV hydrocortisone 100 mg every 8 hours is essential because adrenal insufficiency frequently coexists in myxedematous patients and steroids must be given before or simultaneously with levothyroxine to prevent adrenal crisis. Supportive care includes ICU admission for mechanical ventilation if needed, passive external rewarming (NOT active rewarming, which can cause shock), careful fluid management, and treatment of the precipitating infection or cause. Passive rewarming is preferred because aggressive core rewarming can cause sudden cardiovascular collapse in severely hypothermic patients. The patient’s metabolism is profoundly depressed, so medications are metabolized slowly; sedation should be minimized. Monitoring for hyponatremia (SIADH is common) is important. Recovery is typically slow, with clinical improvement over days to weeks as core temperature normalizes and thyroid hormone stores replete.

---

Disposition

Asymptomatic or Mild Hyperthyroidism: Discharge home with beta-blocker therapy (propranolol or atenolol), clear return precautions (fever, chest pain, palpitations, AMS), and urgent follow-up with primary care or endocrinology within 3–7 days to initiate thionamide therapy and investigate the underlying cause. Encourage compliance with medications and advise the patient to avoid stressors and infections.

Symptomatic Thyrotoxicosis / Impending Storm: Admit to a monitored inpatient medicine service. Continue aggressive pharmacologic management as outlined above. Endocrinology consultation is obtained. Monitoring of vital signs, cardiac rhythm, and mental status is continued. Repeat thyroid function tests, electrolytes, and liver function tests are obtained in 24–48 hours to assess response to therapy. Thionamide therapy is continued until thyroid hormone levels normalize, typically over days to weeks. The patient is transitioned to oral formulations as tolerated and discharged once clinically stable with endocrinology follow-up in place.

Thyroid Storm: Immediate ICU admission. All supportive infrastructure (mechanical ventilation capability, vasopressor availability, continuous cardiac monitoring, central line access) must be established. The intensive care team coordinates with endocrinology and internal medicine. The full treatment cascade is implemented without delay. Complications such as atrial fibrillation with rapid ventricular response, acute pulmonary edema, or seizure are managed aggressively. Mortality remains significant (10–15% even with modern intensive care), so preemptive management of complications and early transfer to a facility with advanced capabilities (ECMO, extracorporeal support) may be warranted in severe cases. The precipitant is identified and treated. Once thyroid hormone levels normalize and organ dysfunction reverses, the patient is transitioned to oral therapy and eventually discharged to follow-up endocrinology and internal medicine care.

---

References

1. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-277. PubMed
2. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. PubMed
3. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006;35(4):663-686, vii. PubMed
4. Angell TE, Lechner MG, Nguyen CT, et al. Clinical features and mechanism of development of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2015;100(1):153-161. PubMed
5. Satoh T, Isozaki O, Suzuki A, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (first edition). Endocr J. 2016;63(12):1025-1064. PubMed
6. Ringel MD. Management of hypothyroidism and hyperthyroidism. Obstet Gynecol. 2016;127(2):e32-e40. PubMed
7. Dushyanthen S, Aniss A, Pearce P, et al. Thyroid crisis: Thyroid storm and acute severe thyroiditis. Aust Fam Physician. 2011;40(10):753-757. PubMed
8. Sweeney LB, Malabanan AO, Nicoloff JT. Thyrotoxicosis. Emerg Med Clin North Am. 1989;7(4):885-902. PubMed
9. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-917. PubMed
10. Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96(2):385-403. PubMed

---